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In clinical trials, highly exploratory secondary endpoints
are common and the number of measured variables
plausibly associated with response can be numerous,
particularly if biomarkers are considered. Automated,
single-best-model selection procedures are widely
employed in such instances. Known issues are: 1) the
precision of parameter estimates are estimated as if the
selected model was prespecified and 2) useful competing
models are disregarded. By contrast, information-theoretic
approaches to model averaging (IT-MA) incorporate
model selection uncertainty and combine parameter
estimates across models.
Two IT-MA estimators exist: the ‘standard’ and the
shrinkage estimator. The latter has been considered pre-
viously in the context of linear regression. We extend
this by exploring IT-MA estimator properties in logistic
regression simulation studies and compare results to
minimum AIC selection (mAIC).
In the extreme case where no explanatory variables are
related to response, the confidence interval coverage of
both IT-MA estimators is near-nominal in sharp contrast
to mAIC, even with a prudent number of events-per-
variable. In the presence of collinearity we demonstrate
that for r>0.7, both IT-MA estimators exhibit bias but
have considerably lower variances than the full model.
Interestingly, for true zero effects the standard IT-MA
estimator is preferable whilst for non-zero effects the
shrinkage estimator is preferable.
In conclusion, confidence interval coverage for
IT-MA is superior to mAIC and both IT-MA estima-
tors perform well even in the presence of collinearity.
These results emphasise the usefulness of IT-MA as a
tool for modelling exploratory secondary endpoints in
clinical trials.
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